STOCK TITAN

Thorne HealthTech, Inc. - THRN STOCK NEWS

Welcome to our dedicated page for Thorne HealthTech news (Ticker: THRN), a resource for investors and traders seeking the latest updates and insights on Thorne HealthTech stock.

Thorne HealthTech, Inc. (NASDAQ: THRN) is a trailblazer in the health and wellness sector, dedicated to providing personalized healthcare solutions. By integrating dietary guidance and lifestyle recommendations with nutritional supplement interventions, Thorne is at the forefront of preventive health care.

Thorne offers at-home biomarker tests, allowing users to gain deep insights into their health from the comfort of their homes. These insights are powered by sophisticated analytical software, enabling personalized plans on diet, exercise, and supplement intake. Thorne's unique approach ensures users can confidently take action to optimize their health outcomes.

Notably, Thorne is the only supplement manufacturer collaborating with the Mayo Clinic for health and wellness research. Additionally, it partners with over 12 USA teams and is trusted by professional athletes and healthcare professionals alike, bolstering its reputation in the industry.

Recently, Thorne announced its second-quarter 2023 financial results, showcasing record net sales and a 33% growth in sales driven by robust demand for its premium wellness offerings. The company continues to expand its product portfolio and strengthen its brand awareness through new marketing campaigns.

In a major development, Thorne entered into a definitive agreement with L Catterton, a leading global consumer-focused investment firm, to acquire all outstanding shares of Thorne's common stock. This transaction, valued at approximately $680 million, underscores Thorne's market significance and commitment to driving long-term growth.

Thorne's mission is to empower individuals to take control of their health through personalized wellness solutions. With a dedicated team and cutting-edge technology, Thorne is well-positioned to remain a leader in the health and wellness industry.

Rhea-AI Summary
L Catterton successfully completes acquisition of Thorne HealthTech, Inc.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
L Catterton and Thorne HealthTech, Inc. announced the expiration of the tender offer to purchase all shares of Thorne's common stock. 97.3% of the shares were tendered and not withdrawn, satisfying all conditions of the offer. The acquisition is expected to be completed on October 16, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.1%
Tags
none
-
Rhea-AI Summary
L Catterton to acquire Thorne HealthTech for $10.20 per share in cash, representing a 94% premium to the unaffected price.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
29.19%
Tags
Rhea-AI Summary
Thorne HealthTech, Inc. (NASDAQ: THRN) reports a 33.1% increase in net sales to $72.7 million and a 35.7% growth in gross profit to $40.6 million for the second quarter of 2023. The company also raised its full-year guidance for net sales and gross margin, with updated ranges of $285 million to $290 million for net sales and 50% to 52% for gross profit as a % of net sales. Thorne HealthTech achieved a net income of $4.4 million and adjusted EBITDA of $12.5 million, leading to a diluted EPS of $0.08 and adjusted diluted EPS of $0.15. Additionally, the company earned CE Mark certification for its at-home blood sampling device in the European Union.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.82%
Tags
-
Rhea-AI Summary
Thorne HealthTech, Inc. (NASDAQ: THRN) will release its second quarter 2023 financial results on Aug. 8, 2023. The company will host a conference call to discuss the results on the same day at 5:00 p.m. (U.S. Eastern Time). Thorne HealthTech has withdrawn its participation in the Canaccord Genuity 43rd Annual Growth Conference on Aug. 10, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.59%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.07%
Tags
conferences
Rhea-AI Summary
Thorne HealthTech, Inc. (NASDAQ: THRN) announces its Build to Last campaign, featuring Dwyane Wade and his son Zaire, highlighting the company's commitment to innovative, high-quality, personalized health and wellness products. The campaign emphasizes the Wades' partnership with Thorne to share their wellness journey and promote Thorne's suite of premium nutritional supplements. Thorne's comprehensive approach to health and wellness is rooted in personalization and scientific rigor, empowering consumers to make choices to optimize their health at every age and life stage.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.19%
Tags
none
-
Rhea-AI Summary
Thorne HealthTech's NanoDrop device receives CE Mark certification, expanding the company's line of innovative health-care solutions. The device allows individuals to collect capillary whole-blood samples at home, making it suitable for decentralized clinical trials and at-home diagnostic testing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.97%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.51%
Tags
partnership

FAQ

What is the market cap of Thorne HealthTech (THRN)?

The market cap of Thorne HealthTech (THRN) is approximately 550.6M.

What is Thorne HealthTech, Inc.?

Thorne HealthTech, Inc. is a health and technology company specializing in personalized healthcare solutions through dietary and lifestyle recommendations combined with nutritional supplements.

What are Thorne's core services?

Thorne offers at-home biomarker tests, personalized dietary and exercise plans, and nutritional supplements to help users optimize their health.

Who are Thorne's key partners?

Thorne collaborates with the Mayo Clinic and partners with over 12 USA teams, including professional athletes and healthcare professionals.

How did Thorne perform in the second quarter of 2023?

Thorne reported record net sales and a 33% growth in sales for the second quarter of 2023, driven by strong demand for its premium wellness offerings.

What is Thorne's recent major business development?

Thorne entered into an agreement with L Catterton to be acquired for approximately $680 million, marking a significant milestone for the company.

How does Thorne leverage technology in its services?

Thorne uses advanced analytical software to provide personalized health insights and plans based on at-home biomarker test results.

What is Thorne's mission?

Thorne aims to empower individuals to take control of their health and achieve healthy aging through personalized wellness solutions.

What sets Thorne apart from other supplement manufacturers?

Thorne is the only supplement manufacturer that collaborates with the Mayo Clinic on health and wellness research.

Who are Thorne's primary customers?

Thorne serves more than five million customers, over 47,000 healthcare professionals, thousands of professional athletes, and numerous professional sports teams.

Where can I find more information about Thorne?

For more information, visit Thorne's official website at www.thorne.com.
Thorne HealthTech, Inc.

Nasdaq:THRN

THRN Rankings

THRN Stock Data

550.63M
14.30M
73.8%
10.28%
0.52%
Packaged Foods
Consumer Defensive
Link
United States
New York